Operating
Income and other taxes
Pfizer Income and other taxes remained flat by 0.0% to -$701.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 108.6%, from -$336.25M to -$701.25M. Over 4 years (FY 2021 to FY 2025), Income and other taxes shows a downward trend with a 24.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 26, 2026
How to read this metric
An increase represents a source of cash (deferred payment), while a decrease indicates a cash outflow as tax liabilities are settled with authorities.
Detailed definition
This reflects the change in the company's liability for income and other taxes that have been accrued but not yet paid....
Peer comparison
Standard across all corporate entities subject to income and property taxes.
Metric ID:
operating_increase_decrease_in_accrued_taxes_payableHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$1.17B | -$545.00M | -$982.00M | -$1.35B | -$2.81B |
| YoY Change | — | +53.3% | -80.2% | -37.0% | -108.6% |
Range-$2.81B – -$545.00M
CAGR+24.5%
Avg YoY Growth-43.1%
Median YoY Growth-58.6%
Current Streak3 years decline
Income and other taxes at Other Companies
Frequently Asked Questions
- What is Pfizer's income and other taxes?
- Pfizer (PFE) reported income and other taxes of -$701.25M in Q4 2025.
- How has Pfizer's income and other taxes changed year-over-year?
- Pfizer's income and other taxes decreased by 108.6% year-over-year, from -$336.25M to -$701.25M.
- What is the long-term trend for Pfizer's income and other taxes?
- Over 4 years (2021 to 2025), Pfizer's income and other taxes has grown at a 24.5% compound annual growth rate (CAGR), from -$1.17B to -$2.81B.
- What does income and other taxes mean?
- The change in the amount of taxes the company owes but has not yet paid.